Search

La extensión, la docencia y la investigación son funciones primordiales de la universidad. Estas misiones se deberían interrelacionar en las políticas institucionales para enriquecerse recíprocamente. La extensión latinoamericana se consolida como un campo heterogéneo, multidimensional y en permanente construcción. El propósito de este artículo es analizar la concepción de extensión que subyace en el marco normativo aprobado en la UNLPam entre 2010 - 2017. Se realizó un relevamiento de las reglamentaciones, del Estatuto y de los planes estratégicos. Se analizó la visión de extensión, su reconocimiento académico y la integración de las funciones. El periodo de estudio puede considerarse clave para la extensión en la UNLPam; porque se consensuó un marco institucional y normativo que propició su mayor jerarquización. Se sentaron las bases para pensarla desde una perspectiva crítica y desde la integralidad de las funciones. Este nuevo escenario propició una mayor participación y valorización de esta misión.

BACKGROUND:Cystic echinococcosis (CE) is an important zoonotic disease caused by the cestode parasite Echinococcus granulosus. It occurs in many parts of the world where pastoral activities predominate, including the Rio Negro province of Argentina. Although CE control activities have been undertaken in the western regions of Rio Negro for more than two decades, the disease continues to remain prevalent in both the human and livestock animal populations. Vaccination of animal intermediate hosts of CE with the EG95 vaccine may provide a new opportunity to improve the effectiveness of CE control measures, although data are lacking about field application of the vaccine. AIMS:Evaluate the impact of EG95 vaccination in sheep on the transmission of Echinococcus granulosus in a field environment. METHODOLOGY:Two trial sites were established in western Rio Negro province within indigenous communities. Vaccination of lambs born into one trial site was introduced and continued for 6 years. Prior to initiation of the trial, and at the end of the trial, the prevalence of CE in sheep was determined by necropsy. Weaned lambs received two injections of EG95 vaccine, approximately one month apart, and a single booster injection one year later. Vaccination was not implemented at the second trial site. A total of 2725 animals were vaccinated in the first year. Animals from this cohort as well as age-matched sheep from the control area were evaluated by necropsy. KEY RESULTS:Introduction of the vaccine led to a statistically significant in the number and size of hydatid cysts in comparison to the situation prior to the introduction of the vaccine, or compared to CE prevalence in the control area where the vaccine was not applied. The prevalence of infection in the vaccinated area was also significantly reduced by 62% compared to the re-intervention level, being lower than the prevalence seen in the control area, although the difference from the control area after the intervention was not significant possibly due to limitations in the numbers of animals available for necropsy. CONCLUSIONS:Vaccination of sheep with the EG95 vaccine provides a valuable new tool which improves the effectiveness of CE control activities. Vaccination was effective even in a difficult, remote environment where only approximately half the lambs born into the communities were fully vaccinated.

There is little information on the humoral response of sheep experimentally infected with Echinococcus granulosus. Thus, the objective of this study was to evaluate this response and measure its evolution. Doses of 10, 100, 1000 and 10000 E. granulosus eggs were prepared and inoculated via intraruminal puncture. Blood samples were obtained before inoculation and every 48 h after inoculation, until they became seropositive. Thereafter, they were taken monthly for the first year and then every three months until 1700 days of observation had been completed. An ELISA test, with total hydatid fluid antigen, was used for immunodiagnosis. The average optical density of the 12 inoculated sheep was found to be above the mean cutoff value 10 days after inoculation, went on increasing until 180 days after inoculation and remained above the cutoff level until the end of the observation period. This confirms that the antibody response of sheep to E. granulosus infection occurs before production of hydatid fluid and that activation, mobilization and establishment of oncospheres in the tissues generates a persistent response from the host's immune system.

En la Provincia de Río Negro, Argentina, se presentaron casos humanos de síndrome pulmonar por hantavirus (SPH) en la región de la cordillera andino patagónica. El virus Andes ha sido identificado en la región, tanto en el roedor Oligoryzomys longicaudatus como en seres humanos, demostrándose la transmisión principalmente del roedor al hombre y la factibilidad de la transmisión de persona a persona. El objetivo del presente trabajo es presentar nueva información sobre especies de roedores portadores de hantavirus en Argentina, su prevalencia de anticuerpos para hantavirus (período 1999-2001) y la relación del tamaño de las poblaciones de roedores y su seroprevalencia con la ocurrencia de casos humanos (período 1996-2001). Para ello, se procedió a la colocación de 3973 trampas para captura viva de roedores, tipo sherman en seis operativos efectuados entre octubre de 1999 y mayo de 2001. Se obtuvieron muestras de sangre de los roedores las que fueron procesadas mediante enzimoinmunoensayo con antígenos elaborados a partir de virus Andes. Una síntesis de los resultados indica 397 roedores capturados, con un éxito de trampeo del 10% y una prevalencia de anticuerpos contra hantavirus del 1.0%. Se observaron importantes diferencias en las especies capturadas en cada una de las regiones. Se capturaron O. longicaudatus y A. Olivaceus seropositivos y O. flavescens y C. Laucha potencialmente portadores de hantavirus Se registraron 6 casos humanos en el período 1993-1995 (correspondientes a estudios retrospectivos), 21 casos se notificaron en el período 1996-1998 y 6 en el período 1999-2001 Se analiza la correlación entre ocurrencia de casos humanos, seroprevalencia en roedores y éxito de trampeo.In the Province of Río Negro, Argentina, human cases of hantavirus pulmonary syndrome (HPS) have occurred in the region of the Patagonian Andean range. The Andes virus has been identified in the region, both in the rodent Oligoryzomys longicaudatus and in human beings, demonstrating mainly transmission from rodents to human and the possibility of person-to-person transmission. The goal of this paper is to present new information on hantavirus rodent carrier species in Argentina, the prevalence of antibodies to hantavirus (1999-2001 period) and the relationship of the rodent population size and seroprevalence with the occurrence of human cases (1996-2001 period). To this end, a total of 3,973 Sherman type traps for capturing live rodents were placed in six campaigns from October 1999 to May 2001. Rodent blood samples were obtained and processed by means of enzymoimmunoassay with antigens developed from the Andes virus. A summary of results indicates 397 captured rodents, with a 10% trapping success rate and a 1.0% prevalence of antibodies to hantavirus. Considerable differences were observed in species captured in each region. Seropositive O. longicaudatus and A. olivaceus specimens, as well as potential hantavirus O. flavescens and C. laucha carriers, were captured. Six human cases were recorded during the 1993-1995 period (corresponding to retrospective studies), while 21 cases were reported in 1996-1998 and 6 in 1999-2001. The correlation between occurrence of human cases, seroprevalence in rodents and trapping success is analyzed.